OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib

Kate Middleton Opens Up About Cancer Recovery: Why Healing Is Not Always Linear

Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate

We Live in Time: When Cancer Changes the Meaning of Time

Preoperative Single-Fraction and Fractionated Stereotactic Radiotherapy Show Comparable Outcomes in Resectable Brain Metastases

Oncology News, Insights, Stories by OncoDaily

Precision Medicine in Colorectal Cancer: Harnessing the Power of MRD Surveillance and Emerging Guidelines
Projects

Precision Medicine in Colorectal Cancer: Harnessing the Power of MRD Surveillance and Emerging Guidelines

Pimicotinib
FDA Approvals

FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results

Joe Biden
Celebrities and Cancer

Joe Biden Says Prostate Cancer Is Slowing Him Down Ahead of Memoir Release

Kate Middleton Opens Up About Cancer Recovery: Why Healing Is Not Always Linear

Mohammad Al Nahedh Takes On Role of Oncology Medical Head at Novartis

Skin After Radiation Therapy: Burns, Healing Stages, and Care

European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma

10 Must-Read Posts in GI Oncology This Week

Lived Experience Advocacy Hub Webinar Opportunity: AI in Oncology

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Voices
Caryn Lerman

Caryn Lerman: What Happens When You're No Longer in Charge?

Cristian Massacesi: Who Will Lead Bristol Myers Squibb’s Newly Unified R and D Organization?

Gilberto Lopes Discusses What Matters Most to People Living With Lung Cancer

Ana Tsereteli: Advancing Oncology Through Learning and Global Collaboration in Venice

Jasmine Kamboj։ Reflections and Learning Through ASCO Health Policy Community of Practice

Don S. Dizon: Celebrating a Full-Circle Moment at UpToDate’s Editors Meeting

Sumit Kumar: Can We Really Skip Radiotherapy in Early Breast Cancer?

FDA Approvals
Pimicotinib

FDA Approves Pimicotinib for TGCT Following Positive Phase 3 MANEUVER Trial Results

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

Excellence in Oncology Care (EIOC 2026)

INDEX Conferences & Exhibitions

13 Nov
Excellence in Oncology Care

ISCO 2026 Fall Clinical Meeting

Idaho Society of Clinical Oncology (ISCO)

13 Nov
ISCO 2026

The ESMO Advanced Course on Cholangiocarcinoma 2026

European Society For Medical Oncology (ESMO)

13 Nov
Advanced Course on Cholangiocarcinoma

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2026

Mayo Clinic

13 Nov
Hepato-Pancreatico-Biliary Cancer

Best of Precision and Immuno-Oncology Conference 2026

OncologyEducation

13 Nov
Immuno-Oncology Conference

The PSOH Annual Meeting 2026

Pennsylvania Society of Oncology & Hematology (PSOH)

14 Nov
PSOH Annual Meeting

Rare Cancers Conference 2026: Advances in Diagnosis, Genomics, and Targeted Therapies

Binaytara

14 Nov
Rare Cancers Conference

The HSCO 2026 Annual Conference

Hawaii Society of Clinical Oncology

14 Nov
HSCO 2026

ESMO AI and Digital Oncology Congress 2026

European Society For Medical Oncology (ESMO)

16 Nov
ESMO

NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research

National Cancer Institute

16 Nov
NCI Data Jamboree

ESTRO Advanced Imaging in Radiotherapy: Current Use, Future Developments, and the Integration of AI

European Society for Radiotherapy and Oncology (ESTRO)

16 Nov
Radiotherapy

Career Masterclass for Early Career Cancer Researchers

European Association for Cancer Research

17 Nov
Early Career Cancer Researchers

Immune-oncology
Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer

Antibiotics and Immunotherapy: What a 97,850-Patient Meta-Analysis Reveals

Beyond Checkpoint Inhibitors: The Rise of T-Cell Engagers in Prostate Cancer

Rituximab and Checkpoint Inhibitors: A New Strategy to Prevent Immune-Related Toxicity

PD-L1: One Biomarker, Three Different Scores

NEO-CESQ Trial: Can Molecular Biomarkers Predict Recurrence After Immunotherapy?

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

Gastrointestinal-Oncology
Tumor Budding in Colorectal Cancer: Grading and Prognosis

Tumor Budding in Colorectal Cancer: Grading and Prognosis

CEA Levels in Colorectal Cancer: Monitoring and Recurrence

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

10 Must-Read Posts in GI Oncology This Week

UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

ABC-06 Trial: Prognostic Tumour Markers and Quality of Life With Second-Line FOLFOX in Advanced BTC

Breast-Oncology
Breast

A Second Chance at Breast Conservation: Reirradiation Challenges Mastectomy After Local Recurrence

Breast Cancer in Michelangelo’s Sistine Chapel? A 500-Year-Old Fresco Sparks a Modern Medical Debate

Premenopausal Breast Cancer: New Review Challenges One-Size-Fits-All Adjuvant Treatment Strategies

Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

DESTINY-Breast09 Redefines First-Line HER2-Positive Breast Cancer: Balancing Efficacy, Safety, and Treatment Selection

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Lung-Oncology
TROP2

Beyond TROP2 Expression: AI-Based Biomarker May Predict Datopotamab Deruxtecan Benefit in Lung Cancer

Beyond EGFR Mutations: New Study Reveals Why Some Lung Cancer Cells Survive Osimertinib

Split-Course Lung SBRT: Novel Inhale–Exhale Technique May Reduce Rib and Chest Wall Radiation Exposure

HERON-Lung01: Ruzaltatug Rezetecan Reduces Progression Risk in EGFR-Mutated NSCLC Following EGFR-TKI Therapy

SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients

Small Cell Lung Cancer in Algeria in 2026: A Chemosensitive Disease That Leaves Little Room for Delay

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

OncoDaily TV
Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Not To Miss
Prostate Cancer

New Prostate Cancer Screening Guidelines Recommend Regular PSA Testing

Daiichi Sankyo Seeks Japan Approval for Trastuzumab Deruxtecan in HER2-Expressing Uterine Carcinosarcoma

Faeth Therapeutics Reports Phase 2 Results for PIKTOR in Endometrial Cancer

Beyond First-Generation ICIs: Module 2 of OncoDaily Academy’s Six-Part Programme on Immune Checkpoint Inhibitors

Save the Date: Boston Will Become a Meeting Place for the Future of GI Oncology

Adagene Completes Phase 2 Enrollment for Muzastotug Plus Pembrolizumab in MSS Colorectal Cancer

European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma

OncoGrants
AAPM

AAPM Global Health Research Seed Funding Grant 2027

Upstream Research Center

Upstream Research Center Cancer Equity Pilot Grants 2027

Oncology Nursing Foundation

Oncology Nursing Foundation Doctoral Scholarships 2027

Clinical Unit Visit Fellowship

International Cancer Foundation Clinical Unit Visit Fellowship 2027–2028

MRF

MRF Career Development Award 2027

Barbara S. Goodman

ICRF Barbara S. Goodman Pancreatic Cancer Award 2027–2028

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Tung Nguyen

Tung Nguyen

Oncologists Location Hanoi, Vietnam
Solange Peters

Solange Peters

Oncologists Location Lausanne, Switzerland
Ting Bao

Ting Bao

Oncologists Location Boston, USA
Fatjona Kraja

Fatjona Kraja

Oncologists Location Tirana, Albania
Maria T. Bourlon, MD, MSc, FASCO

María Teresa Bourlon

Oncologists Location Mexico City, Mexico
El Hadji Daouda Niang

El Hadji Daouda Niang

Oncologists Location Dakar, Senegal
Kleida Mati

Kleida Mati

Oncologists Location Tirana, Albania
Salvatore Provenzano

Salvatore Provenzano

Oncologists Location Milan, Italy

Drugs Atlas
Mosunetuzumab (Lunsumio, Lunsumio Velo): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Mosunetuzumab-axgb (Lunsumio) Nov 13, 2026 1:26 am
Epcoritamab (Epkinly): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Epcoritamab-bysp (Epkinly) Nov 13, 2026 1:25 am
Blinatumomab (Blincyto): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Blinatumomab (Blincyto) Nov 12, 2026 5:42 am
Inotuzumab Ozogamicin (Besponsa): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Inotuzumab ozogamicin (Besponsa) Nov 12, 2026 5:40 am
Gemtuzumab Ozogamicin (Mylotarg): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Gemtuzumab ozogamicin (Mylotarg) Nov 12, 2026 5:37 am
Brentuximab Vedotin (Adcetris): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Brentuximab Vedotin (Adcetris) Nov 12, 2026 5:35 am
Alemtuzumab (Campath, Lemtrada): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Alemtuzumab (Campath, Lemtrada) Nov 10, 2026 4:31 pm
Elotuzumab (Empliciti): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Elotuzumab (Empliciti) Nov 10, 2026 4:26 pm
Isatuximab (Sarclisa, Sarclisa Escena): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Isatuximab-irfc (Sarclisa, Sarclisa Escena) Nov 8, 2026 1:29 am
Daratumumab (Darzalex, Darzalex Faspro): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Daratumumab (Darzalex, Darzalex Faspro) Nov 8, 2026 1:28 am

OncoDaily Magazine

New Paper Alert
Stephanie Lim

Alexandra Thoms Presents Research on Young-Onset Colorectal Cancer at COSA 2026

Nicholas Huntington

Nicholas Huntington: NK Cell-Dendritic Cell Interactions, A New Strategy to Overcome Resistance to Immunotherapy

Çetin Ordu

Çetin Ordu: New Study Supports Genomic Testing in Early-Stage Breast Cancer

Melvin L.K. Chua

Melvin L.K. Chua: An Important Achievement for Nasopharyngeal Carcinoma Research and Clinical Practice

Luciano Costa

Luciano Costa: The “BALI” Strategy for Preventing Infections in Multiple Myeloma Patients

Gilberto Lopes

Gilberto Lopes: New Research Reveals Elevated Long-Term Heart Risks in Young Cancer Survivors

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews